跳至主要内容
临床试验/ACTRN12624000397516
ACTRN12624000397516尚未招募Unknown

Exploring whether home-based neuromodulation can boost the potential analgesic effects of exercise in people with knee osteoarthritis

Western Sydney University0 个研究点目标入组 24 人开始时间: 2024年4月3日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants will be deemed eligible if they meet the National Institute for Health and Care Excellence (NICE) diagnosis guidelines for clinical knee OA28 - are 45 years of age or older, have activity-related joint pain, and have either no morning joint-related stiffness or morning stiffness that lasts no longer than 30 minutes. We will also require participants to report an average weekly pain intensity score during movement of at least 40mm on a 100mm online visual analogue scale (VAS) with terminal descriptors of ‘no pain’ (0mm) and ‘extreme pain’ (100mm). Participants will require access to an electronic communication device (e.g., smartphone, tablet, or computer) for video conferencing sessions. Participants will be excluded if they have undergone knee or neurological surgery over the previous 12 months, present with neurological or musculoskeletal conditions affecting lower limb function, present with other chronic pain conditions (chronic low back pain, rheumatoid arthritis, fibromyalgia, etc.), present with contraindications to exercise as assessed by the Physical Activity Readiness Questionnaire (PAR-Q)29 or have contraindications to receiving tDCS (such as the presence of implanted medical devices in the head or a history of serious brain injury). Participants will be asked to report any drugs that currently take at the time of the trial, with the medication type and dosage recorded during the baseline assessment. Participants will be excluded if they take any drugs known to interfere with tDCS such as benzodiazepines, as previously described.30 Other than drugs that may interfere with tDCS, participants will be permitted to continue to use their normal medications.

排除标准

  • Participants will be excluded if they have undergone knee surgery over the previous 12 months, present with other neurological or musculoskeletal conditions affecting lower limb function, or present with contraindications to exercise or tDCS.

研究者

相似试验